Patents expiring in 2027

US 7255850

Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

The Regents of the University of California · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256028

Methods for screening compounds that modulate lipid metabolism

Xenon Genetics Inc. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256047

Measurement of gluconeogenesis and intermediary metabolism using stable isotopes

The Board of Regents of the University of Texas System · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256171

Use of core 2 G1cNAc transferase inhibitors in treating inflammation

The Regents of the University of California · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256212

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256204

Amine compounds, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256256

CDK4 binding peptide

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256277

Nucleotide and protein sequence of mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256260

Human p53 mutations and a genetic system in yeast for functional identification of human p53 mutations

The United States of America as represented by the Secretary, Dept. of Health and Human Services, NIH · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256279

Protein having ribonucleotide reductase activity and DNA thereof

Takeda Pharmaceutical Company Limited · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7256294

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2002328956

17alfa, 21-dihydroxypregnene esters as antiandrogenic agents

CASSIOPEA S P A [IT] · Granted Thu Aug 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259153

Drug formulation and delivery using crystalline methylated cyclodextrins

Supernus Pharmaceuticals, Inc. · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7258859

Method for the treatment of multiple sclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7258863

Heterologous protection induced by immunization with invaplex vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259236

RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof

The Regents of the University of California · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259261

Racemization and enantiomer separation of clopidogrel

TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259167

Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259278

Anti-S-phase tubulin ligands

Cytoskeleton, Inc. · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259142

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7259161

Compositions useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7261875

Dendritic poly (amino acid) carriers and methods of use

The Board of Regents of the University of Texas System · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7262027

Polypeptide and DNA immunization against Coccidioides spp. infections

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7262205

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7262185

Benzazepine derivative, process for producing the same, and use

Takeda Chemical Industries Ltd. · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7261896

Methods for preventing strokes by inducing tolerance to e-selectin

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7262288

Nucleic acids encoding human telomerase reverse transcriptase and related homologs

The Regents of the University of Colorado · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7262218

Forms of pravastatin sodium

TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7261882

Methods for treating neuropathic pain by administering IL-10 polypeptides

The Regents of the University of Colorado · Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264798

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265157

Sustained release compositions, process for producing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265186

Multi-arm block copolymers as drug delivery vehicles

Nektar Therapeutics AL, Corporation · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265215

DNA or RNA encoding a recombinant dengue envelope protein

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264813

Therapeutic uses of Dunaliella powder

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264799

Use of heparinases to decrease inflammatory response

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264804

Kits for detecting anti-SIRS antibodies

Regents of the University of Minnesota · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265091

Methods and compositions for treating male erectile dysfunction

The Regents of the University of California · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264947

Activity dependent neurotrophic factor III (ADNF III)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265083

Treatment of idiopathic pulmonary fibrosis using IP-10

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265086

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265133

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264820

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline

The Regents of the University of California · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7265208

Fusion molecules and treatment of IgE-mediated allergic diseases

The Regents of the University of California · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7264816

Virulent systemic feline calicivirus

The Regents of the University of California · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7268148

Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7268118

Thymosin β4 compositions

United States of America as represented by the Secretary of the Air Force · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7268122

Use of oversulfated polysaccharides as inhibitors of HIV

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)